Carbapenemase production is constantly increasing among different Enterobacterales species. We analyzed the microbiological characteristics and population structure of all carbapenemase-producing Enterobacter spp. (CP-Ent) isolates recovered at the Ramón y Cajal Hospital between 2005 and 2018. Overall, 178 CP-Ent isolates (60.7% colonization, 39.3% clinical) were recovered from 165 hospitalized patients (165/176, 93.7%; medical [102/165], surgical [34/165], and intensive care unit [29/165] areas), emergency unit (4/176, 2.3%), and ambulatory patients (7/176, 4.0%). In addition, three CP-Ent were found in environmental sources. Clinical samples were mainly urine (37.1%). The most frequent matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF)-identified species were Enterobacter cloacae (n = 85) and Enterobacter asburiae (n = 49). hsp60 gene sequencing showed a higher species diversity than MALDI-TOF: 70 Enterobacter hormaechei-clusters III, VI, VIII; 69 Enterobacter roggenkampii-IV; 15 Enterobacter kobei-II; 9 E. asburiae-I; 3 Enterobacter ludwigii-V; and 1 E. cloacae subsp. dissolvens-XII. Nine Klebsiella aerogenes were also identified. Overall, a high clonal diversity (Simpson Diversity Index >0.90) was found among CP-Ent-clusters. Environmental isolates were clonally related to clinical ones. Amikacin and tigecycline showed the highest susceptibility (>93%). VIM-1 (n = 133/181, 73.5%) and OXA-48 (n = 34/181, 18.8%) carbapenemases were predominant, followed by KPC-2 (n = 9/181, 5.0%), KPC-3 (n = 2/181, 1.1%), VIM-2 (n = 1/181, 0.6%), and two coproducers (VIM-1+KPC-2 and VIM-1+KPC-3). Extended-spectrum beta-lactamase (ESBL) coproduction (14.4%) emerged in 2012, mainly associated with blaSHV-12 (p < 0.001), E. roggenkampii (p < 0.001), and colonization (p = 0.03). VIM-1- and OXA-48-CP-Ent fecal carriers increased in our hospital, particularly between 2011 and 2018 (p < 0.001). Moreover, KPC and OXA-48 producers emerged in 2010 and 2012, respectively. They superimposed over VIM producers, which were persistently recovered since first detection in 2005. These results depict increased complexity over time of CP-Ent.
Get full access to this article
View all access options for this article.
References
1.
MezzatestaM.L., GonaF., and StefaniS.. 2012. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. Future Microbiol. 7:887–902.
2.
GarinetS., FihmanV., JacquierH., CorvecS., Le MonnierA., GuillardT., CattoirV., ZaharJ.R, WoertherP.L, CarbonnelleE., WargnierA., KernéisS., and MorandP.C.. 2018. Elective distribution of resistance to beta-lactams among Enterobacter cloacae genetic clusters. J. Infect. 77:178–182.
3.
KremerA., and HoffmannH.. 2012. Prevalences of the Enterobacter cloacae complex and its phylogenetic derivatives in the nosocomial environment. Eur. J. Clin. Microbiol. Infect. Dis. 31:2951–2955.
4.
AnnavajhalaM.K., Gomez-SimmondsA., and UhlemannA.C.. 2019. Multidrug-resistant Enterobacter cloacae complex emerging as a global, diversifying threat. Front. Microbiol. 10:44.
5.
Davin-RegliA., LavigneJ.P, and PagèsJ.M.. 2019. Enterobacter spp.: update on taxonomy, clinical aspects, and emerging antimicrobial resistance. Clin. Microbiol. Rev. 32:e00002-19.
6.
OhadS., BlockC., KravitzV., FarberA., PiloS., BreuerR., and RormanE.. 2014. Rapid identification of Enterobacter hormaechei and Enterobacter cloacae genetic cluster III. J. Appl. Microbiol. 116:1315–1321.
7.
HoffmannH., and RoggenkampA.. 2003. Population genetics of the nomenspecies Enterobacter cloacae. Appl. Environ. Microbiol. 69:5306–5318.
8.
DieneS.M., MerhejV., HenryM., El FilaliA., RouxV., RobertC., AzzaS., GavoryF., BarbeV., La ScolaB., RaoultD., and RolainJ.M.. 2013. The rhizome of the multidrug-resistant Enterobacter aerogenes genome reveals how new “killer bugs” are created because of a sympatric lifestyle. Mol. Biol. Evol. 30:369–383.
9.
MunsonE., and CarrollK.. 2019. An update on the novel genera and species and revised taxonomic status of bacterial organisms described in 2016 and 2017. J. Clin. Microbiol. 57:e01181-18.
10.
TindallB.J., SuttonG., and GarrityG.M. 2017. Enterobacter aerogenes Hormaeche and Edwards 1960 (Approved Lists 1980) and Klebsiella mobilis Bascomb et al. 1971 (Approved Lists 1980) share the same nomenclatural type (ATCC 13048) on the Approved Lists and are homotypic synonyms, with consequences for the name Klebsiella mobilis Bascomb et al. 1971 (Approved Lists 1980). Int. J. Syst. Evol. Microbiol. 67:502–504.
11.
BradyC., CleenwerckI., VenterS., CoutinhoT., and De VosP.. 2013. Taxonomic evaluation of the genus Enterobacter based on multilocus sequence analysis (MLSA): proposal to reclassify E. nimipressuralis and E. amnigenus into Lelliottia gen. nov. as Lelliottia nimipressuralis comb. nov. and Lelliottia amnigena comb. nov., respectively, E. gergoviae and E. pyrinus into Pluralibacter gen. nov. as Pluralibacter gergoviae comb. nov. and Pluralibacter pyrinus comb. nov., respectively, E. cowanii, E. radicincitans, E. oryzae and E. arachidis into Kosakonia gen. nov. as Kosakonia cowanii comb. nov., Kosakonia radicincitans comb. nov., Kosakonia oryzae comb. nov. and Kosakonia arachidis comb. nov., respectively, and E. turicensis, E. helveticus and E. pulveris into Cronobacter as Cronobacter zurichensis nom. nov., Cronobacter helveticus comb. nov. and Cronobacter pulveris comb. nov., respectively, and emended description of the genera Enterobacter and Cronobacter. Syst. Appl. Microbiol. 36:309–319.
12.
PeiranoG., MatsumuraY., AdamsM.D, BradfordP., MotylM., ChenL., KreiswirthB.N, and PitoutJ.D.D. 2018. Genomic epidemiology of global carbapenemase-producing Enterobacter spp., 2008–2014. Emerg. Infect. Dis. 24:1010–1019.
13.
PotronA., PoirelL., RondinaudE., and NordmannP.. 2013. Intercontinental spread of OXA-48 β-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Eurosurveillance, 18:31.
14.
Davin-RegliA., and PagèsJ.-M.. 2015. Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment. Front. Microbiol. 6:392.
15.
CantónR., OliverA., CoqueT.M, del CM.. Varela, Pérez-DíazJ.C, and BaqueroF.. 2002. Epidemiology of extended-spectrum β-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J. Clin. Microbiol. 40:1237–1243.
16.
CornagliaG., AkovaM., AmicosanteG., CantónR., CaudaR., DocquierJ.D, EdelsteinM., FrèreJ.M, FuziM., GalleniM., GiamarellouH., GniadkowskiM., KoncanR., LibischB., LuzzaroF., MiriagouV., NavarroF., NordmannP., PaganiL., PeixeL., PoirelL., SouliM., TacconelliE., VatopoulosA., and RossoliniG.M.. 2007. Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int. J. Antimicrob. Agents, 29:380–388.
17.
Hernández-GarcíaM., Pérez-VisoB., Carmen TurrientesM., Díaz-AgeroC., López-FresneñaN., BontenM., Malhotra-KumarS., Ruiz-GarbajosaP., and CantónR.. 2018. Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones. J. Antimicrob. Chemother. 73:3039–3043.
18.
HunterP.R., and GastonM.A.. 1988. Numerical index of the discriminatory ability of typing systems: an application of Simpson's Index of Diversity. J. Clin. Microbiol. 26:2465–2466.
19.
Rice, L.B. 2008. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 197:1079–1081.
20.
ChavdaK.D., ChenL., FoutsD.E, SuttonG., BrinkacL., JenkinsS.G, BonomoR.A, AdamsM.D, and KreiswirthB.N.. 2016. Comprehensive genome analysis of carbapenemase-producing Enterobacter spp.: new insights into phylogeny, population structure, and resistance mechanisms. MBio, 7:e02093-16.
21.
AkovaM., DaikosG.L, TzouvelekisL., and CarmeliY.. 2012. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin. Microbiol. Infect. 18:439–448.
22.
ZhouK., YuW., CaoX., ShenP., LuH., LuoQ., RossenJ.W.A, and XiaoY.. 2018. Characterization of the population structure, drug resistance mechanisms and plasmids of the community-associated Enterobacter cloacae complex in China. J. Antimicrob. Chemother. 73:66–76.
23.
HoffmannH., StindlS., LudwigW., StumpfA., MehlenA., MongetD., PierardD., ZiesingS., HeesemannJ., RoggenkampA., and SchleiferK.H.. 2005. Enterobacter hormaechei subsp. oharae subsp. nov., E. hormaechei subsp. hormaechei comb. nov., and E. hormaechei subsp. steigerwaltii subsp. nov., three new subspecies of clinical importance. J. Clin. Microbiol. 43:3297–3303.
24.
MokrackaJ., KoczuraR., PawŁowskiK., and KaznowskiA.. 2011. Resistance patterns and integron cassette arrays of Enterobacter cloacae complex strains of human origin. J. Med. Microbiol. 60:737–743.
25.
MorandP.C., BilloetA., RottmanM., Sivadon-TardyV., EyrolleL., JeanneL., TaziA., AnractP., CourpiedJ.P, PoyartC., and DumaineV.. 2009. Specific distribution within the Enterobacter cloacae complex of strains isolated from infected orthopedic implants. J. Clin. Microbiol. 47:2489–2495.
26.
CabralA.B., MacielM.A.V, BarrosJ.F, AntunesM.M, Barbosa De CastroC.M.M, and Souza LopesA.C.. 2017. Clonal spread and accumulation of β-lactam resistance determinants in Enterobacter aerogenes and Enterobacter cloacae complex isolates from infection and colonization in patients at a public hospital in Recife, Pernambuco, Brazil. J. Med. Microbiol. 66:70–77.
27.
OteoJ., SaezD., BautistaV., Fernández-RomeroS., Hernández-MolinaJ.M, Pérez-VázquezM., AracilB., and CamposJ.. 2013. Carbapenemase-producing Enterobacteriaceae in Spain in 2012. Antimicrob. Agents Chemother. 57:6344–6347.
28.
VillaJ., ViedmaE., BrañasP., OrellanaM.A, OteroJ.R, and ChavesF.. 2014. Multiclonal spread of VIM-1-producing Enterobacter cloacae isolates associated with In624 and In488 integrons located in an IncHI2 plasmid. Int. J. Antimicrob. Agents, 43:451–455.
TatoM., CoqueT.M, Rucz-GarbajosaP., PintadoV., CoboJ., SaderH.S, JonesR.N, BaqueroF., and CantonR.. 2007. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-β-lactamase in Spain: toward endemicity?. Clin. Infect. Dis. 45:1171–1178.
31.
GijónD., TedimA.P, ValverdeA., RodríguezI., MorosiniM.-I, CoqueT., ManriqueM., ParejaE., TobesR., Ruiz-GarbajosaP., and CantónR.. 2020. Early OXA-48-producing Enterobacterales isolates recovered in a Spanish hospital reveal a complex introduction dominated by sequence type 11 (ST11) and ST405 Klebsiella pneumoniae clones. MSphere, 5:e00080-20.
32.
FernándezJ., MonteroI., Ó. Martínez, FleitesA., PoirelL., NordmannP., and RodicioM.R.. 2015. Dissemination of multiresistant Enterobacter cloacae isolates producing OXA-48 and CTX-M-15 in a Spanish hospital. Int. J. Antimicrob. Agents, 46:469–474.
33.
Díaz-AgeroC., López-FresneñaN., Rincon CarlavillaA.L, Hernandez GarciaM., Ruiz-GarbajosaP., Aranaz-AndrésJ.M, MaechlerF., GastmeierP., BontenM.J.M, and CantonR.. 2019. Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: a prevalence survey in a Spanish University Hospital. BMJ Open, 9:e024879.
Garza-GonzálezE., IbarraS.I.M, Llaca-DíazJ.M, and GonzalezG.M.. 2011. Molecular characterization and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico. J. Med. Microbiol. 60:84–90.
36.
HaenniM., SarasE., PonsinC., DahmenS., PetitjeanM., HocquetD., and MadecJ.Y.. 2016. High prevalence of international ESBL CTX-M-15-producing Enterobacter cloacae ST114 clone in animals. J. Antimicrob. Chemother. 71:1497–1500.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
